
QIAGEN N.V. QGEN
Geschäftsbericht 2024
hinzugefügt 24.01.2026
QIAGEN N.V. ROE 2011-2026 | QGEN
ROE Jährlich QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.34 | 8.96 | 12.21 | 16.55 | 12.84 | -1.63 | 7.23 | 1.59 | 3.08 | 4.97 | 4.4 | 2.54 | 4.77 | 3.77 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.55 | -1.63 | 5.97 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Trinity Biotech plc
TRIB
|
287.88 | $ 0.83 | -5.96 % | $ 61.9 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.35 | -2.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 34.5 | 2.16 % | $ 371 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
7.87 | $ 219.29 | -0.08 % | $ 160 B | ||
|
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.41 | 0.1 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 26.19 | -0.19 % | $ 792 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
312.48 | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
26.18 | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
-72.81 | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
-96.68 | $ 109.48 | -2.35 % | $ 4.32 B | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
28.72 | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 144.81 | -3.26 % | $ 23 B | ||
|
NeoGenomics
NEO
|
-8.72 | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
IQVIA Holdings
IQV
|
22.63 | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
0.64 | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Personalis
PSNL
|
-40.05 | $ 9.33 | -6.42 % | $ 553 M | ||
|
Medpace Holdings
MEDP
|
48.98 | $ 582.66 | -1.76 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Biodesix
BDSX
|
-205.65 | $ 10.11 | 4.66 % | $ 1.31 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-40.56 | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
-680.23 | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
55.65 | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.66 | -2.02 % | $ 20 B | ||
|
Agilent Technologies
A
|
22.45 | $ 133.33 | 0.07 % | $ 40.5 B |